Sign up
Quantellect · Congress · Trade Detail
NYSE: BIOBio-Rad Laboratories Inc
RepublicanSenate

Tommy Tuberville sold Bio-Rad Laboratories Inc (NYSE: BIO)

Tommy Tuberville (R-AL), a U.S. Senator, has disclosed 2 trades in Bio-Rad Laboratories Inc (BIO) since 2021, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Tommy Tuberville sold $1,001 - $15,000 of Bio-Rad Laboratories Inc (NYSE: BIO) on March 30, 2022. Since that trade, BIO is down -43.60% against the S&P 500 up +68.06%, an outperformance of -111.66%.

Across these filings, Tommy Tuberville has been a balanced trader of BIO (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BIO trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2021–2022

Tommy Tuberville's BIO trades vs the price

BIO is down -43.60% since Tommy Tuberville sold on March 30, 2022, versus +68.06% for the S&P 500.

Performance since this trade

Price change since trade
-43.60%
S&P 500 change since trade
+68.06%
Outperformance vs S&P 500
-111.66%

All Tommy Tuberville BIO trades

TradedTypeSizeReturnEst. profit
March 30, 2022SELL$580.23-43.60%
March 29, 2021BUY$570.04-42.59%-$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Tommy Tuberville & BIO trading FAQ

Is it legal for Tommy Tuberville to trade Bio-Rad Laboratories Inc (BIO) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Bio-Rad Laboratories Inc (BIO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Tommy Tuberville sell BIO?

Tommy Tuberville disclosed a sale of $1,001 - $15,000 of Bio-Rad Laboratories Inc (BIO) on March 30, 2022, according to public STOCK Act filings.

How has BIO performed since Tommy Tuberville's trade?

Since Tommy Tuberville sold BIO on March 30, 2022, the stock is down -43.60%, versus +68.06% for the S&P 500 over the same period, an outperformance of -111.66%.

How many times has Tommy Tuberville traded BIO?

Tommy Tuberville has disclosed 2 BIO trades since 2021 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BIO trades?

Quantellect tracks every disclosed congressional trade in Bio-Rad Laboratories Inc (BIO) on the Bio-Rad Laboratories Inc congressional trading page, which aggregates filings across all members of Congress.

Tommy Tuberville's BIO tradesAll congressional filings for Bio-Rad Laboratories IncTommy Tuberville's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.